Clinton Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Clinton Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,089	Closed	-$209K	–	1042
2017 Q1	$209K	Sell	2,089 -9,964	-83%	-$1.06M	0.01%	860
2016 Q4	$1.3M	Buy	+12,053	New	+$1.41M	0.08%	310
2016 Q3	–	Sell	-28,645	Closed	-$3.05M	–	1154
2016 Q2	$3.05M	Buy	+28,645	New	+$3.33M	0.13%	207
2015 Q4	–	Sell	-2,479	Closed	-$223K	–	947
2015 Q3	$223K	Buy	+2,479	New	+$262K	0.02%	607

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Clinton Group's CBPO Position: Q2 2017 in Review

Clinton Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 2,089 shares — an estimated $209K sold.

Clinton Group first reported a position in CBPO in Q3 2015 and held it in 4 quarters. The position peaked at $3.05M in Q2 2016. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

Clinton Group reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
Clinton Group sold 2,089 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $209K.
Clinton Group first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 4 quarters.
Clinton Group's China Biologic Products Holdings, Inc. position peaked at $3.05M in Q2 2016.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Clinton Group's 13F filing for Q2 2017, filed 14 Aug 2017.